XML 14 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Balance (in shares) at Sep. 30, 2024   36,707,840        
Balance at Sep. 30, 2024 $ 182,560 $ 37 $ 275,771 $ (93,854) $ (9,427) $ 10,033
Balance (in shares) at Sep. 30, 2024       (6,015,496)    
Increase (Decrease) in Stockholders' Equity            
Net income 5,810         5,810
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units 114   114      
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   138,838        
Taxes paid associated with net settlement of stock compensation awards (883)   (883)      
Taxes paid associated with net settlement of stock compensation awards (in shares)   (30,575)        
Common stock repurchase (in shares)       (582)    
Shares swapped to exercise stock options     19 $ (19)    
Stock compensation expense 3,431   3,431      
Forfeitures of restricted stock awards (in shares)   (22,500)        
Balance (in shares) at Dec. 31, 2024   36,793,603        
Balance at Dec. 31, 2024 189,161 $ 37 278,452 $ (93,873) (11,298) 15,843
Balance (in shares) at Dec. 31, 2024       (6,016,078)    
Balance (in shares) at Sep. 30, 2024   36,707,840        
Balance at Sep. 30, 2024 182,560 $ 37 275,771 $ (93,854) (9,427) 10,033
Balance (in shares) at Sep. 30, 2024       (6,015,496)    
Increase (Decrease) in Stockholders' Equity            
Net income 12,861          
Common stock repurchase $ (1,500)          
Shares swapped to exercise stock options (in shares) (1,397)          
Balance (in shares) at Mar. 31, 2025   37,223,165        
Balance at Mar. 31, 2025 $ 196,325 $ 37 278,124 $ (93,901) (10,829) 22,894
Balance (in shares) at Mar. 31, 2025       (6,016,893)    
Balance (in shares) at Dec. 31, 2024   36,793,603        
Balance at Dec. 31, 2024 189,161 $ 37 278,452 $ (93,873) (11,298) 15,843
Balance (in shares) at Dec. 31, 2024       (6,016,078)    
Increase (Decrease) in Stockholders' Equity            
Net income 7,051         7,051
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units 78   78      
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   522,121        
Taxes paid associated with net settlement of stock compensation awards (3,957)   (3,957)      
Taxes paid associated with net settlement of stock compensation awards (in shares)   (119,819)        
Acquisition consideration paid in common stock 945   945      
Acquisition consideration paid in common stock (in shares)   27,260        
Common stock repurchase (in shares)       (815)    
Shares swapped to exercise stock options     28 $ (28)    
Stock compensation expense 2,578   2,578      
Balance (in shares) at Mar. 31, 2025   37,223,165        
Balance at Mar. 31, 2025 $ 196,325 $ 37 278,124 $ (93,901) (10,829) 22,894
Balance (in shares) at Mar. 31, 2025       (6,016,893)    
Balance (in shares) at Sep. 30, 2025 37,317,175 37,317,175        
Balance at Sep. 30, 2025 $ 203,242 $ 37 285,721 $ (110,002) (10,640) 38,126
Balance (in shares) at Sep. 30, 2025 (6,640,580)     (6,640,580)    
Increase (Decrease) in Stockholders' Equity            
Net income $ 7,489         7,489
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units 738 $ 1 737      
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   224,396        
Taxes paid associated with net settlement of stock compensation awards (1,168)   (1,168)      
Taxes paid associated with net settlement of stock compensation awards (in shares)   (40,301)        
Common stock repurchase (1,473)     $ (1,473)    
Common stock repurchase (in shares)       (55,246)    
Shares swapped to exercise stock options     67 $ (67)    
Shares swapped to exercise stock options (in shares)       (2,388)    
Stock compensation expense 6,174   6,174      
Foreign currency translation 263       263  
Balance (in shares) at Dec. 31, 2025   37,501,270        
Balance at Dec. 31, 2025 $ 215,265 $ 38 291,531 $ (111,542) (10,377) 45,615
Balance (in shares) at Dec. 31, 2025       (6,698,214)    
Balance (in shares) at Sep. 30, 2025 37,317,175 37,317,175        
Balance at Sep. 30, 2025 $ 203,242 $ 37 285,721 $ (110,002) (10,640) 38,126
Balance (in shares) at Sep. 30, 2025 (6,640,580)     (6,640,580)    
Increase (Decrease) in Stockholders' Equity            
Net income $ 15,011          
Common stock repurchase (in shares) (56,676)          
Shares swapped to exercise stock options (in shares) (3,519)          
Balance (in shares) at Mar. 31, 2026 37,873,724 37,873,724        
Balance at Mar. 31, 2026 $ 222,068 $ 38 291,480 $ (111,618) (10,969) 53,137
Balance (in shares) at Mar. 31, 2026 (6,700,775)     (6,700,775)    
Balance (in shares) at Dec. 31, 2025   37,501,270        
Balance at Dec. 31, 2025 $ 215,265 $ 38 291,531 $ (111,542) (10,377) 45,615
Balance (in shares) at Dec. 31, 2025       (6,698,214)    
Increase (Decrease) in Stockholders' Equity            
Net income 7,522         7,522
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units 151   151      
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   573,106        
Taxes paid associated with net settlement of stock compensation awards (4,588)   (4,588)      
Taxes paid associated with net settlement of stock compensation awards (in shares)   (149,559)        
Common stock repurchase $ (40)     $ (40)    
Common stock repurchase (in shares) (1,430)     (1,430)    
Shares swapped to exercise stock options     36 $ (36)    
Shares swapped to exercise stock options (in shares)       (1,131)    
Stock compensation expense $ 4,350   4,350      
Forfeitures of restricted stock awards (in shares)   (51,093)        
Foreign currency translation $ (592)       (592)  
Balance (in shares) at Mar. 31, 2026 37,873,724 37,873,724        
Balance at Mar. 31, 2026 $ 222,068 $ 38 $ 291,480 $ (111,618) $ (10,969) $ 53,137
Balance (in shares) at Mar. 31, 2026 (6,700,775)     (6,700,775)